The Net Margin of Xbrane Biopharma AB (XBRANE.ST) is -133.97%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | -133.97% |
2023-12-31 | -162.60% |
2022-12-31 | -299.41% |
2021-12-31 | -64.61% |
2020-12-31 | -216.34% |
2019-12-31 | -3015.02% |